SPATA7 Antikörper (C-Term)
Kurzübersicht für SPATA7 Antikörper (C-Term) (ABIN954913)
Target
Alle SPATA7 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 341-369, C-Term
-
Spezifität
- This antibody recognizes SPATA7 / HSD3 at C-term.
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human
-
Aufreinigung
- Purified through a Protein A column followed by peptide affinity purification
-
Immunogen
- Synthetic peptide - KLH conjugated - corresponding to the C-terminal region (between 341-369aa) of human SPATA7 / HSD3
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) Sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- SPATA7 (Spermatogenesis Associated 7 (SPATA7))
-
Andere Bezeichnung
- SPATA7 / HSD3
-
Hintergrund
- The SPATA7 gene, originally isolated from testis, is also expressed in retina. Mutations in this gene are associated with Leber's congenital amaurosis (LCA) and juvenile retinitis pigmentosa. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.Synonyms: HSD-3.1, Spermatogenesis-associated protein 7
-
Gen-ID
- 55812
-
NCBI Accession
- NP_001035518
Target
-